USANA Health Sciences, Inc.
USNA
$23.83
$0.090.38%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 213.61M | 200.22M | 212.87M | 227.80M | 221.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 213.61M | 200.22M | 212.87M | 227.80M | 221.08M |
| Cost of Revenue | 38.55M | 39.26M | 40.33M | 43.07M | 42.32M |
| Gross Profit | 175.06M | 160.96M | 172.54M | 184.73M | 178.76M |
| SG&A Expenses | 166.85M | 145.36M | 154.70M | 160.06M | 154.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 205.40M | 184.62M | 195.03M | 203.13M | 196.86M |
| Operating Income | 8.21M | 15.60M | 17.84M | 24.67M | 24.22M |
| Income Before Tax | 10.43M | 18.61M | 20.20M | 27.11M | 26.61M |
| Income Tax Expenses | 5.95M | 8.00M | 9.77M | 10.57M | 9.85M |
| Earnings from Continuing Operations | 4.48M | 10.61M | 10.43M | 16.54M | 16.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -30.00K | -- | -- | -- | -- |
| Net Income | 4.45M | 10.61M | 10.43M | 16.54M | 16.77M |
| EBIT | 8.21M | 15.60M | 17.84M | 24.67M | 24.22M |
| EBITDA | 12.21M | 19.17M | 21.65M | 27.83M | 27.13M |
| EPS Basic | 0.23 | 0.56 | 0.55 | 0.86 | 0.87 |
| Normalized Basic EPS | 0.34 | 0.61 | 0.66 | 0.88 | 0.86 |
| EPS Diluted | 0.23 | 0.56 | 0.54 | 0.86 | 0.87 |
| Normalized Diluted EPS | 0.34 | 0.61 | 0.66 | 0.88 | 0.86 |
| Average Basic Shares Outstanding | 19.10M | 19.08M | 19.07M | 19.17M | 19.25M |
| Average Diluted Shares Outstanding | 19.10M | 19.08M | 19.16M | 19.30M | 19.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |